Drug Delivery

Catalent Appoints New Vice-President of Operations

February 12, 2020

Jim Walter will take on the role of vice-president of operations for Catalent’s Oral and Specialty Delivery business.

Eli Lilly to Invest $470 Million into New Pharma Manufacturing Facility

January 27, 2020

The facility will produce parenteral products and delivery devices and is set to create 460 new jobs.

CPI Partners with ImmunoBiology for Heat-Stabilized Formulation of Pneumococcal Vaccine

December 05, 2019

CPI has partnered with ImmunoBiology (ImmBio) for the development of a heat-stabilized formulation of a mutli-antigen vaccine candidate against Pneumococcal diseases.

Lonza, Cryoport Partner in Cell and Gene Therapy Field

November 21, 2019

Lonza and Cryoport have partnered up to strengthen Lonza’s ‘vein-to-vein’ delivery network by removing supply chain hurdles faced by developers of personalized therapeutics.

Improving the Patient Experience with High Viscosity/High Volume Drugs

October 17, 2019

On Tuesday, Nov. 5, 2019, Karima Yadi from Becton Dickinson & Co. will present the challenges of using, and necessity for, shorter needles and integrated systems with high viscosity drugs, such as biologics, to improve the patient experience at CPhI Worldwide.

FDA Approves AstraZeneca Asthma Drug in Auto-Injector Pen

October 11, 2019

AstraZeneca received approval from FDA for Fasenra Pen, a pre-fillled auto-injector pen that allows for self-administration of its asthma biologic therapy, Fasenra (benralizumab).

FDA Approves First Oral GLP-1 Treatment for Type 2 Diabetes

September 23, 2019

FDA has approved Novo Nordisk’s Rybelsus (semaglutide), a glucagon-like peptide receptor protein treatment in oral tablet form for type 2 diabetes.

Hikma Launches Prefilled Syringes in the US for Heparin

September 19, 2019

The company will supply its heparin sodium injection in prefilled syringe form.

Sanofi, Abbott Partner to Advance Diabetes Management

September 16, 2019

The companies aim to integrate glucose sensing with insulin delivery technologies to help change the way diabetes is managed.

Collaboration Aims to Drive Commercialization of Next-Generation Therapies

September 13, 2019

TrakCel and McKesson have formed a collaboration that is aimed at accelerating commercialization of cell and gene therapies by leveraging services to enable a more efficient development pathway.